ARTICLE | Clinical News
Aurograb: Phase II data
September 1, 2008 7:00 AM UTC
A Phase II trial to treat deep-seated S. aureus infection showed that IV Aurograb twice-daily plus vancomycin for 7 days showed a “lack of efficacy” compared with vancomycin monotherapy. Novartis deci...